CORBUS PHARMACEUTICALS HOLDI (CRBP)
US21833P3010 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -44.60M | -42.35M | -45.64M | -111.27M | -71.45M | |||
| Depreciation Amortization | 640.60K | 760.00K | 1.00M | 1.12M | 740.00K | |||
| Change In Working Capital | 3.27M | -4.02M | -15.70M | -3.20M | 12.48M | |||
| Interest Paid | 2.61M | 1.97M | 1.74M | 630.00K | 30.00K | |||
| Other non cash items | 4.59M | 8.06M | 12.15M | 13.66M | 12.52M | |||
| OPERATING CASH FLOW | -36.10M | -37.54M | -48.18M | -99.69M | -45.72M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -10.00K | -50.00K | -480.00K | -2.74M | |||
| Other Investing Activity | 35.64M | 30.09M | -73.36M | N/A | N/A | |||
| INVESTING CASH FLOW | 35.64M | 30.07M | -73.42M | -480.00K | -2.74M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -2.87M | -530.00K | 60.00K | 18.71M | 360.00K | |||
| Stock Issued/Repurchased | 244.30K | 0.00 | 62.59M | 142.20M | 40.68M | |||
| Other Financing Activity | -190.90K | 0.00 | -1.82M | -6.04M | -2.57M | |||
| FINANCING CASH FLOW | -2.82M | -530.00K | 60.82M | 154.87M | 38.46M | |||
| CHANGE IN CASH | -3.28M | -8.00M | -60.78M | 54.70M | -10.00M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -36.10M | -37.54M | -48.18M | -99.69M | -45.72M | |||
| Capital Expenditure | 0.00 | -10.00K | -50.00K | -480.00K | -2.74M | |||
| FREE CASH FLOW | -36.10M | -37.55M | -48.23M | -100.17M | -48.46M | |||
All data in USD